Double-blind, Randomized, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BP101 After Multiple Doses Administration in Healthy Volunteers
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 21 Aug 2017
At a glance
- Drugs BP 101 (Primary)
- Indications Female sexual dysfunction
- Focus Adverse reactions
- Sponsors Ivix
- 15 Aug 2017 Status changed from recruiting to active, no longer recruiting.
- 14 Apr 2017 Status changed from active, no longer recruiting to recruiting.
- 06 Apr 2017 New trial record